THE TGA has published the
fourth edition of its Medicines
Safety Update on its website.
The new edition features an
update on Varenicline (Champix)
and including product summary
information, psychiatric symptoms
reported with varenicline and what
to include in an varenicline a
adverse reaction report.
The Medicines Safety Update
also includes a report on the
Australian experience with nonadjuvant
H1N1 vaccine (Panvax
and Panvax Junior), as well as
information on the new TGA
structural arrangements.
The Update also features details
on what to report.
To view a copy of the Safety
Update see www.tga.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 03 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Aug 10
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.